Related Experiment Video
Updated: Nov 17, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relationship between renal volume and atherosclerosis in nondiabetic hypertensive patients with normal glomerular
Emrah Selvi1, Aysun Aybal Kutlugun2, Nuray Gulden Tangal3
1Department of Internal Medicine, Health Science University, Keçioren Training and Research Hospital, Ankara, Turkey.
Insights
Renal volume, measured by ultrasound, can predict atherosclerosis in hypertensive patients. This easy method aids in early detection of cardiovascular risk factors.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Cystatin C (CysC) and cardiovascular risk are linked in hypertensive patients.
- Limited research exists on renal volume's association with atherosclerosis.
- This study explores CysC, renal volume, and atherosclerosis in hypertension.
Purpose of the Study:
- To investigate the association between renal volume, cystatin C (CysC), and atherosclerosis in hypertensive patients.
- To determine if renal volume predicts subclinical atherosclerosis (measured by CIMT).
- To assess the utility of ultrasonographic renal volume measurement in hypertensive individuals.
Main Methods:
- 133 hypertensive patients and 80 controls were assessed.
- Blood samples for CysC, carotid intima-media thickness (CIMT), and renal volume via ultrasound were measured.
- Statistical analysis compared laboratory findings, CysC, CIMT, and renal volume between groups.
Main Results:
- No significant difference in renal volume between hypertensive and control groups.
- CIMT was significantly higher in hypertensive patients (p=.003).
- Renal volume correlated significantly with CIMT (r=0.213, p=.001) and independently predicted it.
Conclusions:
- Ultrasonographic renal volume measurement is a simple, quick method.
- Renal volume can be a useful predictor of atherosclerosis in hypertensive patients with GFR >60 ml/min.
- This imaging technique may aid in early cardiovascular risk assessment.
Abstract:
Background: The association between cystatin C (CysC) and atherosclerosis has been shown in numerous studies in hypertensive patients and in various patient groups with high cardiovascular risk. The study examining the association between renal volume and atherosclerosis is very limited. This study aimed to investigate whether there is an association between the presence of atherosclerosis with CysC and renal volume in hypertensive patients.Methods: 133 hypertensive patients and 80 healthy volunteers were evaluated. CysC level was studied in the blood sample taken from all participants. Carotid intima media thickness (CIMT) and renal volume were measured with ultrasound always by the same radiologist. Laboratory findings, CysC, CIMT, and renal volume measurements of the groups were compared statistically.Results: There was no significant difference in mean renal volume values between hypertension and control groups. There was no significant correlation between renal volume with albuminuria and proteinuria. CIMT was significantly higher in hypertension group than in control group (p = .003). There was a significant correlation between renal volume and CIMT, which is an indicator of subclinical atherosclerosis (r = 0.213, p = .001). Renal volume was found to be an independent predictor of CIMT when corrected with variables such as age, BMI, serum LDL-cholesterol level, creatinine, CysC, and albumin-to-creatinine ratio.Conclusion: Ultrasonographic renal volume measurement, which is easy to perform and does not take a long time, can be a useful method for predicting the presence of atherosclerosis in hypertensive patients with GFR >60 ml/min.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Antihypertensive Drugs: Action of Diuretics
Hypertension II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors

